Synopsis
Synopsis
0
VMF
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 3,3',5-triiodothyronine
2. Cytomel
3. Liothyronine
4. T3 Thyroid Hormone
5. Thyroid Hormone, T3
6. Triiodothyronine
1. 55-06-1
2. Cytomel
3. Triostat
4. 3,3',5-triiodo-l-thyronine Sodium Salt
5. Tertroxin
6. T3 Sodium Salt
7. Basoprocin
8. Ibiothyron
9. Cynomel
10. Triiodothyronine Sodium
11. L-triiodothyronine Sodium Salt
12. Cytobin
13. 3,3',5-triiodo-l-thyronine Sodium
14. 3,3',5-triiodothyronine Sodium Salt
15. Triiodothyronine Sodium Salt
16. L-tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-, Monosodium Salt
17. Liotrix (t3)
18. Chebi:6484
19. Liothyronine (sodium)
20. Monosodium L-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine
21. Gca9vv7d2n
22. Liothyronine (l- Isomer) Sodium
23. Rathyronine Sodium, (s)-
24. Cytomel Sodium
25. Lyothyronin
26. Nsc-80774
27. Nsc-758175
28. 3,3'',5-triiodo-l-thyronine Sodium Salt
29. Ro Thyronine
30. Sodium Triiodothyronine
31. Liothyronine Sodium Salt
32. Alanine, 3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-, Monosodium Salt, L-
33. Sodium Liothyronine
34. Sodium T3
35. Sodium Triiodotironine
36. Sodium-l-triiodothyronine
37. Mls000028648
38. L-triiodothyronine Hydrochloride
39. Sodium (s)-2-amino-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)propanoate
40. Rathyronine Hydrochloride, (s)-
41. Sodium Triiodothyronine, L-
42. Sodium 3,5,3'-triiodothyronine
43. Sodium L-3,5,3'-triiodothyronine
44. Smr000059206
45. Einecs 200-223-5
46. Unii-gca9vv7d2n
47. Mfcd00002594
48. Nsc 80774
49. Sodium 3,3',5-triiodo-l-thyronine
50. Sodium 3,5,3'-triiodo-l-thyronine
51. L-3,3',5-triiodothyronine Sodium Salt
52. Triostat (tn)
53. Cytomel (tn)
54. Liothyronine Sodium [usp:ban:jan]
55. Ibiot
56. L-tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-, Sodium Salt (1:1)
57. Sodium;(2s)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoate
58. O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-l-tyrosine Sodium Salt
59. T-3
60. Epitope Id:136777
61. T3 (liotrix)
62. T3, Na
63. Dsstox_cid_27505
64. Dsstox_rid_82385
65. Dsstox_gsid_47505
66. Schembl41654
67. 3,3',5-l-triiodothyronine
68. Spectrum1502047
69. Chembl1201119
70. Dtxsid8047505
71. Liothyronine Sodium [jan]
72. Nrp-409
73. Liothyronine Sodium (jp17/usp)
74. Hms1921h18
75. Hms2092b14
76. Liothyronine Sodium [vandf]
77. Act03263
78. Amy38143
79. Hy-a0070
80. Liothyronine Sodium [mart.]
81. Sodium L-3,3',5-triiodothyronine
82. Tox21_302514
83. Triiodothyronine Sodium, Levo
84. Ccg-39522
85. Liothyronine Sodium [usp-rs]
86. Liothyronine Sodium [who-dd]
87. Liotrix (t3) [orange Book]
88. S4217
89. Liothyronine Sodium Salt [mi]
90. Akos015918421
91. Akos032949712
92. Cs-3241
93. 3,3',5-triiodo-l-thyronine (sodium)
94. Cas-55-06-1
95. Liothyronine Sodium [green Book]
96. Liothyronine Sodium [orange Book]
97. Ncgc00256816-01
98. Ac-31934
99. As-13674
100. L-3,3',5-triiodothyronine, Sodium Salt
101. Liothyronine Sodium [ep Monograph]
102. Liothyronine Sodium [usp Monograph]
103. 3,5,3'-triiodo-l-thyronine Monosodium Salt
104. Sw219577-1
105. D01011
106. F20556
107. A830467
108. Q930170
109. Q-201881
110. 3,3',5-triiodo-l-thyronine Sodium Salt, >=95% (hplc)
111. Liothyronine Sodium, European Pharmacopoeia (ep) Reference Standard
112. O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-l-tyrosine, Monosodium Salt
113. 3,3',5-triiodo-l-thyronine Sodium Salt, Powder, Bioreagent, Suitable For Cell Culture
114. Liothyronine For Peak Identification, European Pharmacopoeia (ep) Reference Standard
115. Sodium (2s)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoate
116. Sodium (2s)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoate
117. 3,3',5-triiodo-l-thyronine Sodium Salt, Gamma-irradiated, Powder, Bioxtra, Suitable For Cell Culture
Molecular Weight | 672.95 g/mol |
---|---|
Molecular Formula | C15H11I3NNaO4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 5 |
Exact Mass | 672.7720 g/mol |
Monoisotopic Mass | 672.7720 g/mol |
Topological Polar Surface Area | 95.6 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 408 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Cytomel |
PubMed Health | Liothyronine |
Drug Classes | Diagnostic Agent, Thyroid Function, Thyroid Supplement |
Drug Label | Thyroid hormone drugs are natural or synthetic preparations containing tetraiodothyronine (T4, levothyroxine) sodium or triiodothyronine (T3, liothyronine) sodium or both. T4 and T3 are produced in the human thyroid gland by the iodination and coupli... |
Active Ingredient | Liothyronine sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 0.05mg base; eq 0.025mg base; eq 0.005mg base |
Market Status | Prescription |
Company | King Pharms R And D |
2 of 6 | |
---|---|
Drug Name | Liothyronine sodium |
Drug Label | Thyroid hormone drugs are natural or synthetic preparations containing tetraiodothyronine (T4, levothyroxine) sodium or triiodothyronine (T3, liothyronine) sodium or both. T4 and T3 are produced in the human thyroid gland by the iodination and coupli... |
Active Ingredient | Liothyronine sodium |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | eq 0.05mg base; eq 0.025mg base; eq 0.005mg base; eq 0.01mg base/ml |
Market Status | Prescription |
Company | X Gen Pharms; Coastal Pharms; Sigmapharm Labs; Mylan |
3 of 6 | |
---|---|
Drug Name | Triostat |
PubMed Health | Liothyronine |
Drug Classes | Diagnostic Agent, Thyroid Function, Thyroid Supplement |
Active Ingredient | Liothyronine sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 0.01mg base/ml |
Market Status | Prescription |
Company | Par Sterile Products |
4 of 6 | |
---|---|
Drug Name | Cytomel |
PubMed Health | Liothyronine |
Drug Classes | Diagnostic Agent, Thyroid Function, Thyroid Supplement |
Drug Label | Thyroid hormone drugs are natural or synthetic preparations containing tetraiodothyronine (T4, levothyroxine) sodium or triiodothyronine (T3, liothyronine) sodium or both. T4 and T3 are produced in the human thyroid gland by the iodination and coupli... |
Active Ingredient | Liothyronine sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 0.05mg base; eq 0.025mg base; eq 0.005mg base |
Market Status | Prescription |
Company | King Pharms R And D |
5 of 6 | |
---|---|
Drug Name | Liothyronine sodium |
Drug Label | Thyroid hormone drugs are natural or synthetic preparations containing tetraiodothyronine (T4, levothyroxine) sodium or triiodothyronine (T3, liothyronine) sodium or both. T4 and T3 are produced in the human thyroid gland by the iodination and coupli... |
Active Ingredient | Liothyronine sodium |
Dosage Form | Tablet; Injectable |
Route | Injection; Oral |
Strength | eq 0.05mg base; eq 0.025mg base; eq 0.005mg base; eq 0.01mg base/ml |
Market Status | Prescription |
Company | X Gen Pharms; Coastal Pharms; Sigmapharm Labs; Mylan |
6 of 6 | |
---|---|
Drug Name | Triostat |
PubMed Health | Liothyronine |
Drug Classes | Diagnostic Agent, Thyroid Function, Thyroid Supplement |
Active Ingredient | Liothyronine sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 0.01mg base/ml |
Market Status | Prescription |
Company | Par Sterile Products |
H - Systemic hormonal preparations, excl. sex hormones and insulins
H03 - Thyroid therapy
H03A - Thyroid preparations
H03AA - Thyroid hormones
H03AA02 - Liothyronine sodium
Certificate Number : CEP 2017-035 - Rev 01
Status : Valid
Issue Date : 2023-11-29
Type : Chemical and TSE
Substance Number : 728
Certificate Number : R1-CEP 2006-249 - Rev 02
Status : Valid
Issue Date : 2023-07-05
Type : Chemical
Substance Number : 728
Certificate Number : R1-CEP 2001-043 - Rev 02
Status : Withdrawn by Holder
Issue Date : 2008-07-22
Type : Chemical
Substance Number : 728
Registration Number : 222MF10255
Registrant's Address : Am Kraftwerk 6, D-66450 Bexbach, Germany
Initial Date of Registration : 2010-11-05
Latest Date of Registration : 2010-11-05
Date of Issue : 2021-02-26
Valid Till : 2023-06-22
Written Confirmation Number : WC-0404A3
Address of the Firm : Plot No.40/A Sy.13,15,16,51,52 &182 J.N Pharma City Thanam village Parawada mand...
Date of Issue : 2020-08-17
Valid Till : 2023-06-22
Written Confirmation Number : WC-0404A2
Address of the Firm : Plot No.40/A Sy.13,15,16,51,52 &182 J.N Pharma City Thanam village Parawada mand...
Date of Issue : 2020-08-17
Valid Till : 2023-06-22
Written Confirmation Number : WC-0404
Address of the Firm : Plot No.40/A Sy.13,15,16,51,52 &182 J.N Pharma City Thanam village Parawada mand...
Date of Issue : 2022-08-08
Valid Till : 2025-07-14
Written Confirmation Number : WC-0168
Address of the Firm : Plot No. 24/2, & 25, Phase -IV, GIDC, Industrial Zone, At & Post - Panoli, Dist....
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2020-11-25
Registration Number : 20201125-211-J-790
Manufacturer Name : Azico Biophore India Private...
Manufacturer Address : Plot Number 40/A, Sy. No. 13,15,16,51,52 & 182, JN.Pharma city, Thanam(V), Anakapalli...
NDC Package Code : 69575-4010
Start Marketing Date : 2016-08-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0354
Start Marketing Date : 2004-04-01
End Marketing Date : 2024-12-27
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 62991-1096
Start Marketing Date : 2009-06-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0031
Start Marketing Date : 2005-06-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-3226
Start Marketing Date : 2020-12-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0282
Start Marketing Date : 2013-06-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 67891-003
Start Marketing Date : 2006-06-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 81955-0009
Start Marketing Date : 1982-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
About the Company : Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-appro...
Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
About the Company : Bioiberica is a global Life Science company with more than 45 years' experience in the production and development of molecules of high biological and therapeutic value for the phar...
About the Company : Aasraw Biochemical Technology Co.,ltd was reorganized by a Shanghai based Biochemical Engineering Laboratory in 2008, which was built by 5 Chinese Ph. Doctors, who are majored at C...
About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Liothyronine is a man-made form of thyroid hormone which is used to treat an underactive thyroid (hypothyroidism). Zydus Cadila has received final approval from the USFDA to market Liothyronine Sodium Tablets USP, 5 mcg, 25 mcg, and 50 mcg (US RLD: Cytomel Tablets).
Lead Product(s): Liothyronine Sodium
Therapeutic Area: Endocrinology Brand Name: Undisclosed
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 23, 2021
Lead Product(s) : Liothyronine Sodium
Therapeutic Area : Endocrinology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Zydus Cadila Receives Final Approval from USFDA for Liothyronine Sodium Tablets
Details : Liothyronine is a man-made form of thyroid hormone which is used to treat an underactive thyroid (hypothyroidism). Zydus Cadila has received final approval from the USFDA to market Liothyronine Sodium Tablets USP, 5 mcg, 25 mcg, and 50 mcg (US RLD: Cytom...
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Not Applicable
January 23, 2021
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MCG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 5MCG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 25MCG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 25MCG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MCG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 5MCG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 20MCG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 20MCG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 20MCG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 20MCG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?